Milestone Scientific (NYSE:MLSS) Now Covered by Analysts at assumed coverage on shares of Milestone Scientific (NYSE:MLSSFree Report) in a research report report published on Wednesday morning. The firm issued a hold rating on the stock.

Milestone Scientific Price Performance

Shares of MLSS opened at $0.67 on Wednesday. Milestone Scientific has a 52 week low of $0.52 and a 52 week high of $1.35. The company has a market capitalization of $51.74 million, a price-to-earnings ratio of -6.70 and a beta of 0.90. The stock’s 50-day moving average price is $0.68 and its 200-day moving average price is $0.66.

Milestone Scientific (NYSE:MLSSGet Free Report) last issued its earnings results on Wednesday, May 15th. The company reported ($0.02) EPS for the quarter. The company had revenue of $2.25 million during the quarter. Milestone Scientific had a negative return on equity of 93.64% and a negative net margin of 74.50%.

Milestone Scientific Company Profile

(Get Free Report)

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.

See Also

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with's FREE daily email newsletter.